The "rebate pumping" and "spread pricing" referenced in the article, "Rebates to pharmacy benefit managers are a hidden contributor to high drug prices," definitely deserves scrutiny as the author suggests.
Read MoreWith more than 20 years of thought leadership in healthcare, Saira’s blog offers insights into health policy legislation and regulation, health advocacy, trends in rare and ultra rare diseases, and more.
Check back for valuable posts.
The heavy scrutiny by Congress, payers, and the media on drug price hikes may be having its intended impact – giving manufacturers pause with respect to the frequency and/or magnitude of price increases. There’s another effect that bears keeping in mind, on the wholesalers that have long operated with a margin-dependent business model that factors price increases into revenue projections
Read More